![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 7
Zeitschriftenartikel
Zimmermann, Heiner; Koenecke, Christian; Dreyling, Martin H.; Pott, Christiane; Duehrsen, Ulrich; Hahn, Dennis; Meidenbauer, Norbert; Hauser, Ingeborg A.; Rummel, Mathias J.; Wolf, Dominik; Heuser, Michael; Schmidt, Christian; Schlattmann, Peter; Ritgen, Matthias; Siebert, Reiner; Oschlies, Ilske; Anagnostopoulos, Ioannis und Trappe, Ralf U.
(2022):
Modified risk-stratified sequential treatment (subcutaneous rituximab with or without chemotherapy) in B-cell Post-transplant lymphoproliferative disorder (PTLD) after Solid organ transplantation (SOT): the prospective multicentre phase II PTLD-2 trial.
In: Leukemia, Bd. 36, Nr. 10: S. 2468-2478
Heuser, Michael; Freeman, Sylvie D.; Ossenkoppele, Gert J.; Buccisano, Francesco; Hourigan, Christopher S.; Ngai, Lok Lam; Tettero, Jesse M.; Bachas, Costa; Baer, Constance; Bene, Marie-Christine; Bucklein, Veit; Czyz, Anna; Denys, Barbara; Dillon, Richard; Feuring-Buske, Michaela; Guzman, Monica L.; Haferlach, Torsten; Han, Lina; Herzig, Julia K.; Jorgensen, Jeffrey L.; Kern, Wolfgang; Konopleva, Marina Y.; Lacombe, Francis; Libura, Marta; Majchrzak, Agata; Maurillo, Luca; Ofran, Yishai; Philippe, Jan; Plesa, Adriana; Preudhomme, Claude; Ravandi, Farhad; Roumier, Christophe; Subklewe, Marion; Thol, Felicitas; Loosdrecht, Arjan A. van de; Reijden, Bert A. van der; Venditti, Adriano; Wierzbowska, Agnieszka; Valk, Peter J. M.; Wood, Brent L.; Walter, Roland B.; Thiede, Christian; Dohner, Konstanze; Roboz, Gail J. und Cloos, Jacqueline
(2021):
2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party.
In: Blood, Bd. 138, Nr. 26: S. 2753-2767
Rautenberg, Christina; Stoelzel, Friedrich; Roellig, Christoph; Stelljes, Matthias; Gaidzik, Verena; Lauseker, Michael; Kriege, Oliver; Verbeek, Mareike; Unglaub, Julia Marie; Thol, Felicitas; Krause, Stefan W.; Haenel, Mathias; Neuerburg, Charlotte; Vucinic, Vladan; Jehn, Christian-Friedrich; Severmann, Julia; Wass, Maxi; Fransecky, Lars; Chemnitz, Jens; Holtick, Udo; Schaefer-Eckart, Kerstin; Schroeder, Josephine; Kraus, Sabrina; Krueger, William; Kaiser, Ulrich; Scholl, Sebastian; Koch, Kathrin; Henning, Lea; Kobbe, Guido; Haas, Rainer; Alakel, Nael; Roehnert, Maximilian-Alexander; Sockel, Katja; Hanoun, Maher; Platzbecker, Uwe; Holderried, Tobias A. W.; Morgner, Anke; Heuser, Michael; Sauer, Tim; Goetze, Katharina S.; Wagner-Drouet, Eva; Doehner, Konstanze; Doehner, Hartmut; Schliemann, Christoph; Schetelig, Johannes; Bornhaeuser, Martin; Germing, Ulrich; Schroeder, Thomas und Middeke, Jan Moritz
(2021):
Real-world experience of CPX-351 as first-line treatment for patients with acute myeloid leukemia.
In: Blood Cancer Journal, Bd. 11, Nr. 10, 164
Montesinos, Pau; Roboz, Gail J.; Bulabois, Claude-Eric; Subklewe, Marion; Platzbecker, Uwe; Ofran, Yishai; Papayannidis, Cristina; Wierzbowska, Agnieszka; Shin, Ho Jin; Doronin, Vadim; Deneberg, Stefan; Yeh, Su-Peng; Ozcan, Mehmet Ali; Knapper, Steven; Cortes, Jorge; Pollyea, Daniel A.; Ossenkoppele, Gert; Giralt, Sergio; Doehner, Hartmut; Heuser, Michael; Xiu, Liang; Singh, Indrajeet; Huang, Fei; Larsen, Julie S. und Wei, Andrew H.
(2020):
Safety and efficacy of talacotuzumab plus decitabine or decitabine alone in patients with acute myeloid leukemia not eligible for chemotherapy: results from a multicenter, randomized, phase 2/3 study.
In: Leukemia, Bd. 35, Nr. 1: S. 62-74
Jawhar, Mohamad; Doehner, Konstanze; Kreil, Sebastian; Schwaab, Juliana; Shoumariyeh, Khalid; Meggendorfer, Manja; Span, Lambert L. F.; Fuhrmann, Stephan; Naumann, Nicole; Horny, Hans-Peter; Sotlar, Karl; Kubuschok, Boris; Bubnoff, Nikolas von; Spiekermann, Karsten; Heuser, Michael; Metzgeroth, Georgia; Fabarius, Alice; Klein, Stefan; Hofmann, Wolf-Karsten; Kluin-Nelemans, Hanneke C.; Haferlach, Torsten; Doehner, Hartmut; Cross, Nicholas C. P.; Sperr, Wolfgang R.; Valent, Peter und Reiter, Andreas
(2019):
KIT D816 mutated/CBF-negative acute myeloid leukemia: a poor-risk subtype associated with systemic mastocytosis.
In: Leukemia, Bd. 33, Nr. 5: S. 1124-1134
Schanda, Julia; Lee, Chun-Wei; Wohlan, Katharina; Müller-Kuller, Uta; Kunkel, Hana; Coco, Isabell Quagliano-Lo; Stein, Stefan; Metz, Alexander; Koch, Joachim; Lausen, Jorn; Platzbecker, Uwe; Medyouf, Hind; Gohlke, Holger; Heuser, Michael; Eder, Matthias; Grez, Manuel; Scherr, Michaela und Wichmann, Christian
(2017):
Suppression of RUNX1/ETO oncogenic activity by a small molecule inhibitor of tetramerization.
In: Haematologica, Bd. 102, Nr. 5, E170-E174
Höckendorf, Ulrike; Yabal, Monica; Herold, Tobias; Munkhbaatar, Enkhtsetseg; Rott, Stephanie; Jilg, Stefanie; Kauschinger, Johanna; Magnani, Giovanni; Reisinger, Florian; Heuser, Michael; Kreipe, Hans; Sotlar, Karl; Engleitner, Thomas; Rad, Roland; Weichert, Wilko; Peschel, Christian; Ruland, Jürgen; Heikenwalder, Mathias; Spiekermann, Karsten; Slotta-Huspenina, Julia; Groß, Olaf und Jost, Philipp J.
(2016):
RIPK3 Restricts Myeloid Leukemogenesis by Promoting Cell Death and Differentiation of Leukemia Initiating Cells.
In: Cancer Cell, Bd. 30, Nr. 1: S. 75-91